Chongqing, China--Porton announced the establishment of Porton U.S.A, LLC, a new subsidiary and Process Innovation Center located in Cranbury, New Jersey (NJ), United States. Deploying state-of-the-art laboratories and some of the industry’s most capable and experienced scientists, Porton’s NJ Center will provide our customers with impactful solutions to complex process challenges, next generation process development, gram to kilogram cGMP syntheses of specialized pharmaceutical intermediates and APIs including highly potent APIs and antibody drug conjugates, etc.  Through flexibly structured, yet close-knit collaborations and geographical proximity, Porton’s NJ Center will bring new efficiencies to pharmaceutical development and lifecycle management for our valued global customers.